These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 1721812)
1. Mutants of human insulin-like growth factor II: expression and characterization of analogs with a substitution of TYR27 and/or a deletion of residues 62-67. Roth BV; Bürgisser DM; Lüthi C; Humbel RE Biochem Biophys Res Commun; 1991 Dec; 181(2):907-14. PubMed ID: 1721812 [TBL] [Abstract][Full Text] [Related]
2. Mutants of human insulin-like growth factor II (IGF II). Expression and characterization of truncated IGF II and of two naturally occurring variants. Lüthi C; Roth BV; Humbel RE Eur J Biochem; 1992 Apr; 205(2):483-90. PubMed ID: 1374027 [TBL] [Abstract][Full Text] [Related]
3. The design, expression, and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate receptor or IGF-I receptor. Sakano K; Enjoh T; Numata F; Fujiwara H; Marumoto Y; Higashihashi N; Sato Y; Perdue JF; Fujita-Yamaguchi Y J Biol Chem; 1991 Nov; 266(31):20626-35. PubMed ID: 1657932 [TBL] [Abstract][Full Text] [Related]
4. Altered affinity of insulin-like growth factor II (IGF-II) for receptors and IGF-binding proteins, resulting from limited modifications of the IGF-II molecule. Oh Y; Beukers MW; Pham HM; Smanik PA; Smith MC; Rosenfeld RG Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):249-54. PubMed ID: 1715685 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs. Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979 [TBL] [Abstract][Full Text] [Related]
6. A mutant of human insulin-like growth factor II (IGF II) with the processing sites of proinsulin. Expression and binding studies of processed IGF II. Zarn JA; Lüthi C; Giger RJ; Sigrist A; Humbel RE Eur J Biochem; 1992 Dec; 210(3):665-9. PubMed ID: 1282887 [TBL] [Abstract][Full Text] [Related]
7. N-terminal deletion mutants of insulin-like growth factor-II (IGF-II) show Thr7 and Leu8 important for binding to insulin and IGF-I receptors and Leu8 critical for all IGF-II functions. Hashimoto R; Fujiwara H; Higashihashi N; Enjoh-Kimura T; Terasawa H; Fujita-Yamaguchi Y; Inagaki F; Perdue JF; Sakano K J Biol Chem; 1995 Jul; 270(30):18013-8. PubMed ID: 7629109 [TBL] [Abstract][Full Text] [Related]
8. Mutants of human insulin-like growth factor II with altered affinities for the type 1 and type 2 insulin-like growth factor receptor. Bürgisser DM; Roth BV; Giger R; Lüthi C; Weigl S; Zarn J; Humbel RE J Biol Chem; 1991 Jan; 266(2):1029-33. PubMed ID: 1845984 [TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factors (IGFs) reduce IGF-binding protein-4 (IGFBP-4) concentration and stimulate IGFBP-3 independently of IGF receptors in human fibroblasts and epidermal cells. Neely EK; Rosenfeld RG Endocrinology; 1992 Feb; 130(2):985-93. PubMed ID: 1370799 [TBL] [Abstract][Full Text] [Related]
10. [Leu27] insulin-like growth factor II is highly selective for the type-II IGF receptor in binding, cross-linking and thymidine incorporation experiments. Beukers MW; Oh Y; Zhang H; Ling N; Rosenfeld RG Endocrinology; 1991 Feb; 128(2):1201-3. PubMed ID: 1846582 [TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II. Francis GL; Aplin SE; Milner SJ; McNeil KA; Ballard FJ; Wallace JC Biochem J; 1993 Aug; 293 ( Pt 3)(Pt 3):713-9. PubMed ID: 7688957 [TBL] [Abstract][Full Text] [Related]
12. Structural analogs of human insulin-like growth factor (IGF) I with altered affinity for type 2 IGF receptors. Cascieri MA; Chicchi GG; Applebaum J; Green BG; Hayes NS; Bayne ML J Biol Chem; 1989 Feb; 264(4):2199-202. PubMed ID: 2536701 [TBL] [Abstract][Full Text] [Related]
13. Mutations at positions 11 and 60 of insulin-like growth factor 1 reveal differences between its interactions with the type I insulin-like-growth-factor receptor and the insulin receptor. Hodgson DR; May FE; Westley BR Eur J Biochem; 1995 Oct; 233(1):299-309. PubMed ID: 7588759 [TBL] [Abstract][Full Text] [Related]
14. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. Francis GL; Ross M; Ballard FJ; Milner SJ; Senn C; McNeil KA; Wallace JC; King R; Wells JR J Mol Endocrinol; 1992 Jun; 8(3):213-23. PubMed ID: 1378742 [TBL] [Abstract][Full Text] [Related]
15. Secretion of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: implications for autocrine growth regulation. Park JH; McCusker RH; Vanderhoof JA; Mohammadpour H; Harty RF; MacDonald RG Endocrinology; 1992 Sep; 131(3):1359-68. PubMed ID: 1380441 [TBL] [Abstract][Full Text] [Related]
16. Expression, purification, and in vitro characterization of recombinant salmon insulin-like growth factor-II. Wilkinson RJ; Elliott P; Carragher JF; Francis G Protein Expr Purif; 2004 Jun; 35(2):334-43. PubMed ID: 15135411 [TBL] [Abstract][Full Text] [Related]
17. Production of biologically active recombinant tilapia insulin-like growth factor-II polypeptides in Escherichia coli cells and characterization of the genomic structure of the coding region. Chen JY; Chang CY; Chen JC; Shen SC; Wu JL DNA Cell Biol; 1997 Jul; 16(7):883-92. PubMed ID: 9260931 [TBL] [Abstract][Full Text] [Related]
18. Roles of insulin-like growth factor (IGF) receptors and IGF-binding proteins in IGF-II-induced proliferation and differentiation of L6A1 rat myoblasts. Bach LA; Salemi R; Leeding KS Endocrinology; 1995 Nov; 136(11):5061-9. PubMed ID: 7588242 [TBL] [Abstract][Full Text] [Related]
19. Binding properties of chimeric insulin receptors containing the cysteine-rich domain of either the insulin-like growth factor I receptor or the insulin receptor related receptor. Zhang B; Roth RA Biochemistry; 1991 May; 30(21):5113-7. PubMed ID: 1645190 [TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of a unique high molecular weight form of insulin-like growth factor II. Gowan LK; Hampton B; Hill DJ; Schlueter RJ; Perdue JF Endocrinology; 1987 Aug; 121(2):449-58. PubMed ID: 2439316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]